1.Department of Neurology, CRC-SEP, University Hospital of Toulouse, Toulouse, France ;2.INSERM U1291–CNRS 5051, INFINITy, Toulouse, France ;3.Immunology Laboratory, Biology Department, University Hospital of Toulouse, Toulouse, France ;
Abstract:
Journal of Neurology - It is currently unknown whether early B cell reconstitution (EBR) in MS patients under rituximab is associated with a risk of relapse or progression. Analyzing EBR in...